The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Andres Iñiguez

Showing 1-20 of 22 articles
Coronary interventions
Bioresorbable scaffolds versus permanent sirolimus-eluting stents in patients with ST-Segment Elevation Myocardial Infarction: vascular healing outcomes from the MAGSTEMI trial
Gomez-Lara J, Ortega-Paz L, Brugaletta S, Cuesta J, Romaní S, Serra A, Salinas P, García del Blanco B, Goicolea J, Hernandez-Antolin R, Antuna P, Romaguera R, Regueiro A, Rivero F, Cequier A, Alfonso F, Gomez-Hospital J, Sabate M, Freixa X, Masotti M, Ferreiro JL, Roura G, Bastante T, Jiménez M, Otaegui I, Bordes P, Iñiguez A
April 21, 2020 | 10.4244/EIJ-D-20-00198
Angiographic and clinical outcomes of STEMI patients treated with bioresorbable or metallic everolimus-eluting stents: a pooled analysis of individual patient data
Cassese S, Katagiri Y, Byrne R, Brugaletta S, Alfonso F, Räber L, Maeng M, Iñiguez A, Kretov E, Onuma Y, Joner M, Sabate M, Laugwitz K, Windecker S, Kastrati A, Serruys P
March 20, 2020 | 10.4244/EIJ-D-18-01080
Transcatheter mitral valve repair in patients with acute myocardial infarction: insights from the European Registry of MitraClip in Acute Mitral Regurgitation following an acute myocardial infarction (EREMMI)
Estevez-Loureiro R, Adamo M, Arzamendi D, Denti P, Freixa X, Nombela-Franco L, Pascual I, Melica B, Attias D, Serrador A, Benito-González T, Iñiguez A, Fernández-Vázquez F
February 20, 2020 | 10.4244/EIJ-D-19-00653
Clinical outcomes of state-of-the-art percutaneous coronary revascularisation in patients with three-vessel disease: two-year follow-up of the SYNTAX II study
Serruys P, Farooq V, Banning A, Escaned J, Wykrzykowska J, Piek J, Dudek D, Ochala A, Hildick-Smith D, Goicolea J, Iñiguez A, Buszman P, Modolo R, Katagiri Y, Kogame N, Onuma Y
June 12, 2019 | 10.4244/EIJ-D-18-00980
Coronary interventions
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial)
Katagiri Y, Onuma Y, Asano T, Iñiguez A, Okkels Jensen L, Cequier A, Hofma S, Christiansen E, Suttorp M, Brugaletta S, Räber L, Sabate M, Windecker S, Serruys P, Räber L, Sabate M, Serruys P
December 7, 2018 | 10.4244/EIJ-D-18-00839
Functional comparison between the BuMA Supreme biodegradable polymer sirolimus-eluting stent and a durable polymer zotarolimus-eluting coronary stent using quantitative flow ratio: PIONEER QFR substudy
Asano T, Katagiri Y, Collet C, Tenekecioglu E, Miyazaki Y, Sotomi Y, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernandez-Antolin R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Reiber J, von Birgelen C, Sabate M, Onuma Y, Serruys P
August 3, 2018 | 10.4244/EIJ-D-17-00461
Long-term clinical outcomes after bioresorbable and permanent polymer drug-eluting stent implantation: final five-year results of the CENTURY II randomised clinical trial
Wijns W, Valdés Chávarri M, Richardt G, Moreno R, Iñiguez A, Barbato E, Carrié D, Ando K, Merkely B, Kornowski R, Eltchaninoff H, Stojkovic S, Saito S
June 14, 2018 | 10.4244/EIJ-D-18-00358
Stents and scaffolds
A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotarolimus-eluting Resolute stent: six-month angiographic and one-year clinical results of the NIREUS trial
Paradies V, Ben-Yehuda O, Jonas M, Banai S, Iñiguez A, Perlman G, Kandzari D, Stone G, Smits P
May 20, 2018 | 10.4244/EIJ-D-17-00890
First-in-man randomised comparison of the BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: the PIONEER trial
von Birgelen C, Asano T, Amoroso G, Aminian A, Brugaletta S, Vrolix M, Hernández-Antolín R, van de Harst P, Iñiguez A, Janssens L, Smits P, Wykrzykowska J, Ribeiro V, Pereira H, da Silva P, Piek J, Onuma Y, Serruys P, Sabate M
April 20, 2018 | 10.4244/EIJ-D-17-00462
Other
Assessing the performance of the PRECISE-DAPT and PARIS risk scores for predicting one-year out-of-hospital bleeding in acute coronary syndrome patients
Abu-Assi E, Raposeiras-Roubin S, Cobas-Paz R, Caneiro-Queija B, Martinez-Reglero C, Rodriguez-Rodriguez JM, Baz A, Iñiguez A
March 20, 2018 | 10.4244/EIJ-D-17-00550
STEMI
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial
Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vázquez N, Valgimigli M, Serruys P, Sabate M
March 20, 2018 | 10.4244/EIJ-D-17-00608
Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial
Filipovic-Pierucci A, Durand-Zaleski I, Butel T, Greene S, Hovasse T, Iñiguez A, Nazzaro M, Oldroyd K, Talwar S, Richardt G, Windhovel U, Urban P, Morice M
February 20, 2018 | 10.4244/EIJ-D-17-00286
Stents and scaffolds
Four-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II Trial)
Chevalier B, Cequier A, Dudek D, Haude M, Carrié D, Sabate M, Windecker S, Reith S, de Sousa Almeida M, Campo G, Iñiguez A, Onuma Y, Serruys P
January 19, 2018 | 10.4244/EIJ-D-17-00873
Coronary interventions
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial
Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jimenez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys P, Sabate M
August 4, 2017 | 10.4244/EIJ-D-16-00512
Interventions for valvular disease
Outcomes and predictors of success and complications for paravalvular leak closure: an analysis of the SpanisH real-wOrld paravalvular LEaks closure (HOLE) registry
Garcia E, Arzamendi D, Jimenez-Quevedo P, Sarnago F, Martí G, Sanchez Recalde A, Lasa-Larraya G, Sancho M, Iñiguez A, Goicolea J, Roman K, Alonso-Briales J, Molina E, Calabuig J, Freixa X, Berenguer A, Valdés Chávarri M, Vázquez N, Diaz J, Cruz-Gonzalez I
March 20, 2017 | 10.4244/EIJ-D-16-00581
Coronary interventions
Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study
Räber L, Onuma Y, Brugaletta S, Garcia-Garcia H, Backx B, Iñiguez A, Okkels Jensen L, Cequier-Fillat A, Pilgrim T, Christiansen E, Hofma S, Suttorp M, Serruys P, Sabate M, Windecker S
July 20, 2016 | 10.4244/EIJY15M08_03
Coronary interventions
Significance of prior percutaneous revascularisation in patients with acute coronary syndromes: insights from the prospective PROSPECT registry
Iñiguez A, Brener S, Jimenez V, Maehara A, Mintz G, Xu K, Weisz G, Lansky A, De Bruyne B, Serruys P, Stone G
April 20, 2016 | 10.4244/EIJV11I13A285
Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials
Taniwaki M, Stefanini G, Räber L, Brugaletta S, Cequier A, Heg D, Iñiguez A, Kelbæk H, Serra A, Ostojic M, Hernández-Antolín R, Baumbach A, Blochlinger S, Jüni P, Mainar V, Sabate M, Windecker S
August 20, 2015 | 10.4244/EIJY14M07_12
Sirolimus-eluting stent versus bare metal stent in diabetic patients: the final five-year follow-up of the DIABETES trial
Jimenez-Quevedo P, Hernando L, Gomez-Hospital J, Iñiguez A, SanRoman A, Alfonso F, Hernández-Antolín R, Angiolillo D, Banuelos C, Escaned J, Gonzalo N, Fernandez C, Macaya C, Sabate M
July 26, 2013 | 10.4244/EIJV9I3A54
Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction
Sabate M, Cequier A, Iñiguez A, Serra A, Hernández-Antolín R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Brugaletta S, Backx B, Serruys P
December 30, 2011 | 10.4244/EIJV7I8A154

Latest news

NEW ISSUE
Special issue on PCR Valves e-Course; patient-centring the Heart Team, COVID and clinical trials...
Optimising the delivery of self-expanding valves according to vascular access
November 20, 2020
NEW
Fatal Acute Mesenteric Ischemia Following Transcatheter Aortic Valve Replacement
November 25, 2020
Editorial
Patient preferences and Heart Team decision
Alec Vahanian
November 20, 2020
Popular Tavi-A, TAILOR-PCI, ATPCI, PORTICO-IDE and more
(Thanks to the support of Biotronik)
November 12, 2020
Guidance Papers
Guidelines, consensus & position papers
August 28, 2020
Editorial
Cardiovascular trials and COVID-19
Alexandra Lansky
November 25, 2020
JAA
This Week's JAA's: Win Ratio for Renal Denervation, Optimal strategy for NSTEMI in the very elderly, D-PUSH OCT Procedure...
November 24, 2020
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke